Literature DB >> 7351122

Inheritance of phenytoin hypometabolism: a kinetic study of one family.

M R Vasko, R D Bell, D D Daly, C E Pippenger.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7351122     DOI： 10.1038/clpt.1980.15

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  13 in total

Review 1.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 2.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

Review 3.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

Review 4.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.

Authors:  C J Doecke; M E Veronese; S M Pond; J O Miners; D J Birkett; L N Sansom; M E McManus
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

6.  Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.

Authors:  A Küpfer; R Preisig
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Variability in drug metabolism: importance of genetic constitution.

Authors:  J H Schellens; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

8.  Noncompliance leading to drug accumulation resulting in phenytoin toxicity.

Authors:  Ravi Akula; Syed Hasan; Rao Pipalla; Clifford Ferguson
Journal:  J Natl Med Assoc       Date:  2003-12       Impact factor: 1.798

Review 9.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

Review 10.  PharmGKB summary: phenytoin pathway.

Authors:  Caroline F Thorn; Michelle Whirl-Carrillo; J Steven Leeder; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-06       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.